Previene o retrasa el inicio | 01 OCT 17

Metformina para la prevención de la diabetes

Datos del Diabetes Prevention Program Outcomes Study el estudio de metformina para la prevención de la diabetes mayor y más prolongado
Autor/a: Aroda VR, Knowler WC Crandall JP et al Diabetologia (2017) 60:1601–1611
INDICE:  1. Página 1 | 2. Referencias bibliográficas
Referencias bibliográficas

1. Diabetes Prevention Program Research Group (1999) The Diabetes Prevention Program. Design and methods for a clinical trial in the prevention of type 2 diabetes. Diabetes Care 22:623–634

2. KnowlerWC, Barrett-Connor E, Fowler SE et al (2002) Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 346:393–403

3. Jarrett RJ, Keen H, Fuller JH, McCartney M (1979) Worsening to diabetes in men with impaired glucose tolerance (“borderline diabetes”). Diabetologia 16:25–30

4. Sartor G, Schersten B, Carlstrom S, Melander A, Norden A, Persson G (1980) Ten-year follow-up of subjects with impaired glucose tolerance: prevention of diabetes by tolbutamide and diet regulation. Diabetes 29:41–49

5. Keen H, Jarrett RJ, McCartney P (1982) The ten-year follow-up of the Bedford survey (1962-1972): glucose tolerance and diabetes. Diabetologia 22:73–78

6. Pan XR, Li GW, Hu YH et al (1997) Effects of diet and exercise in preventing NIDDMin people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study. Diabetes Care 20:537–544

7. Tuomilehto J, Lindstrom J, Eriksson JG et al (2001) Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 344:1343–1350

8. Diabetes Prevention Program Research Group, Knowler WC, Fowler SE et al (2009) 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study. Lancet 374:1677–1686

9. Diabetes Prevention Program Research Group (2015) Long-term effects of lifestyle intervention or metformin on diabetes development and microvascular complications over 15-year follow-up: the Diabetes Prevention Program Outcomes Study. Lancet Diabetes

Endocrinol 3:866–875

10. Aroda VR, Ratner RE (2012) Interventional trials to prevent diabetes: diabetes prevention Program. In: LeRoith D (ed) Prevention of type 2 diabetes: from science to therapy. Springer, New York, pp 143–166

11. American Diabetes Association (1997) Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 20:1183–1197

12. Walker EA, Molitch M, Kramer MK et al (2006) Adherence to preventive medications: predictors and outcomes in the Diabetes Prevention Program. Diabetes Care 29:1997–2002

13. Diabetes Prevention Program Research Group, Hamman RF, Horton E et al (2015) Factors affecting the decline in incidence of diabetes in the Diabetes Prevention Program Outcomes Study (DPPOS). Diabetes 64:989–998

14. Ratner RE, Christophi CA, Metzger BE et al (2008) Prevention of diabetes in women with a history of gestational diabetes: effects of metformin and lifestyle interventions. J Clin Endocrinol Metab 93: 4774–4779

15. Aroda VR, Christophi CA, Edelstein SL et al (2015) The effect of lifestyle intervention and metformin on preventing or delaying diabetes among women with and without gestational diabetes: the Diabetes Prevention Program Outcomes Study 10-year follow-up.

J Clin Endocrinol Metab 100:1646–1653

16. Diabetes Prevention Program Research Group (2003) Effects of withdrawal from metformin on the development of diabetes in the Diabetes Prevention Program. Diabetes Care 26:977–980

 

Comentarios

Para ver los comentarios de sus colegas o para expresar su opinión debe ingresar con su cuenta de IntraMed.

AAIP RNBD
Términos y condiciones de uso | Todos los derechos reservados | Copyright 1997-2023